Brief: Syros Pharmaceuticals Q1 EPS USD -0.1 Vs. IBES Estimate USD -0.87
14/05/2024 12:30
May 14 (Reuters) - Syros Pharmaceuticals Q1 operating expenses USD 30.921 million. * Q1 income from operations USD -30.921 million vs. IBES estimate USD -27.8 million * Q1 net income USD -3.708 million vs. IBES estimate USD -29.8 million
Recent news on Syros Pharmaceuticals
See all newsU.S. STOCKS ON THE MOVE-Elevance, Backblaze, Disney
Syros Pharmaceuticals hits record low on QIAGEN deal termination and leadership changes
U.S. STOCKS ON THE MOVE-Charter Communications, BioNTech, Big US banks
U.S. STOCKS ON THE MOVE-BankUnited, Natera, Adaptimmune
Syros falls after blood cancer drug fails in late-stage trial